Cargando…
Urinary gonadotropin peptide (UGP) in Egyptian patients with benign and advanced malignant urological disease.
Urinary gonadotropin peptide (UGP) levels were determined in urine samples from 450 Egyptian subjects to determine its relative level of expression in benign and malignant urological disease, and normal individuals. The mean UGP level in patients with bladder cancer was 44-fold higher than in patien...
Autores principales: | el-Ahmady, O., Halim, A. B., Mansour, O., Salman, T., el-Din, A. G., Walker, R. P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074546/ https://www.ncbi.nlm.nih.gov/pubmed/8664117 |
Ejemplares similares
-
Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance
por: Wang, Lingxiang, et al.
Publicado: (2018) -
Characterisation of UGP and its relationship with beta-core fragment.
por: Kardana, A., et al.
Publicado: (1993) -
Urinary biomarkers of urological malignancies
por: Fujita, Kazutoshi
Publicado: (2021) -
Structural Basis of Glycerophosphodiester Recognition
by the Mycobacterium tuberculosis Substrate-Binding
Protein UgpB
por: Fenn, Jonathan S., et al.
Publicado: (2019) -
Low UGP2 Expression Is Associated with Tumour Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Hu, Qiuyue, et al.
Publicado: (2020)